Cargando…
PReS-FINAL-2137: Adalimumab monotherapy results in clinical and radiological improvement in newly diagnosed patients with juvenile spondylarthritis (JSPA)/enthesitis related arthritis(ERA)
Autores principales: | Maritsi, D, Soldatou, A, Papaioannou, G, Garoufi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045789/ http://dx.doi.org/10.1186/1546-0096-11-S2-P149 |
Ejemplares similares
-
PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
por: Burgos-Vargas, R, et al.
Publicado: (2013) -
PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013) -
High Prevalence of Ultrasound Verified Enthesitis in Patients With Inflammatory Bowel Disease With or Without Spondylarthritis
por: Husic, Rusmir, et al.
Publicado: (2021) -
Differences of ultrasonographic enthesitis between patients with non-radiographic axial spondylarthritis and ankylosing spondylitis
por: Li, Juan, et al.
Publicado: (2022) -
PReS-FINAL-2020: Cell type specific transcriptome analysis in patients with enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA)
por: Aggarwal, A, et al.
Publicado: (2013)